What can we help you find?

Leading the way in transplantation

Filter results for:

TLJ 2.0: New Papers Published

Following the TLJ 2.0 event last November, two important papers have been published in Transplant International focusing on the meeting’s Workstream 4: Normothermic regional perfusion (NRP) in donation after circulatory death (DCD). One paper concerns a systematic review and meta-analyses of NRP in DCD donation, with the other focuses on a consensus statement on the…

Read more

Management of the patient with HLA antibodies: join the discussion

Recommendations from Workstream 6 of the ESOT Transplantation Learning Journey (TLJ 2.0) project, concerning the management of the patient with HLA antibodies We are pleased to present the recommendations from Workstream 6 of the ESOT Transplantation Learning Journey (TLJ 2.0) project, concerning the management of the patient with HLA antibodies. Over recent months, our group…

Read more

Technical & Logistical aspects of Performing Normothermic Regional Perfusion in Controlled Donation after Circulatory Death in Europe

A working group of European experts has summarised the current technique and logistical aspects as they are implemented in their countries and / or centres. From these discussions, and supported by literature, the TJL2.0 Work Stream has created a list of recommendations and minimal requirements any NRP programme should follow.  We ask your help to…

Read more

The COVID-19 Vaccine Studies

Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader…

Read more

Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer – Open for comments until 06 April

This pre-print from TLJ 2.0 WS03 on ‘Managing Immunosuppressant Therapy in Potentially Cured Post-Kidney Transplant Cancer’ is now open for comments on Transplant Live. Led by Umberto Maggiore, this paper will be submitted to Transplant International once feedback from our community has been collated. Login & provide your input today…

Read more